The future of precision medicine starts here
Our mission is to develop novel microbiome-based therapeutics and companion diagnostics aimed at the prevention and treatment of chronic diseases.
See Our Science
Breaking News:
Siolta Therapeutics receives a Grand Challenges Exploration award
The Grand Challenges Exploration (GCE) program, an initiative supported by the Bill & Melinda Gates Foundation, provides grants to address global health challenges. We are honored to have received a grant (GCE Round 22) supporting the development of novel culturing and manufacturing processes for live biotherapeutic products.
Learn More
Publications
Nature Microbiology
Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance
July 23, 2019
Read More
Nature Microbiology
Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance
July 24, 2019
Read More
News
Inspiring young scientists in collaboration with California Life Sciences Institute (CLSI)
3rd Annual Biotech Week at SFUSD
May 10, 2019
Read More